Page
%P
-
Article
Valutazione economica di ticagrelor vs Clopidogrel nel trattamento di pazienti con sindrome coronarica acuta
Ticagrelor is a new generation drug for the prevention of thrombotic events in patients with acute coronary syndrome (ACS). This study is a cost-effectiveness analysis of ticagrelor vs clopidogrel (the current...
